Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v6-FR
Language French French
Date Updated 2023-12-08 2022-11-09
Drug Identification Number 02432463 02432463
Brand name LODALIS LODALIS
Common or Proper name LODALIS LODALIS
Company Name BAUSCH HEALTH, CANADA INC. BAUSCH HEALTH, CANADA INC.
Ingredients COLESEVELAM HYDROCHLORIDE COLESEVELAM HYDROCHLORIDE
Strength(s) 3.75G 3.75G
Dosage form(s) POWDER FOR SUSPENSION POWDER FOR SUSPENSION
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30ct 30ct
ATC code C10AC C10AC
ATC description LIPID MODIFYING AGENTS, PLAIN LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Shortage of an inactive ingredient or component. Shortage of an inactive ingredient or component.
Anticipated start date 2022-10-31 2022-10-31
Actual start date 2022-10-31 2022-10-31
Estimated end date 2023-08-01
Actual end date 2023-12-01
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Discontinued
Health Canada comments